Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity

Journal of Clinical Investigation

Volumn 102, Issue 6, 1998, Pages 1173-1182

  Estess, Pila ^a   DeGrendele, Heather C ^a   Pascual, Virginia ^a   Siegelman, Mark H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adhesion; Arthritis; Hyaluronate; Inflammation; SLE

Indexed keywords

HERMES ANTIGEN; HYALURONIC ACID; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CELL ADHESION; CHILD; CHRONIC ARTHRITIS; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; EXTRAVASATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHEAR STRESS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE SUBPOPULATION; VASCULAR ENDOTHELIUM;

EID: 0032531108     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4235     Document Type: Article

References (67)

1. Van Boxel, J.A., und S.A. Paget. 1975. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med. 293:517-520.
2. Mackay, C.R. 1991. T-cell memory: the connection between function, phenotype and migration pathways. Immunol. Today. 12:189-192.
3. Picker, L.J., and M.H. Siegelman. 1993. Lymphoid tissues and organs. In Fundamental Immunology. W.E. Paul, editor. Raven Press, New York. 145-197.
4. Lesley, J., R. Hymun, and P.W. Kincade. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335.
5. Haynes, B.F., L.P. Hale, K.L. Patton, M.E. Martin, and R.M. McCallum. 1991. Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis. Arthritis Rheum. 34:1434-1443.
6. Mikecz, K., F.R. Brennan, J.H. Kim, and T.T. Giant. 1995. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis. Nat. Med. 1:558-563.
7. Camp, R.L., A. Scheynius, C. Johansson, and E. Pure. 1993. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178:497-507.
8. Verdrengh, M., R. Holmdahl, and A. Tarkowski. 1995. Administration of antibodies to hyaluronan receptor (CD44) delays the start and ameliorates the severity of collagen II arthritis. Scand. J. Immunol. 42:353-358.
9. DeGrendele, H.C., P. Estess, L.J. Picker, and M.H. Siegelman. 1996. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte/endothelial cell primary adhesion pathway. J. Exp. Med. 183:1119-1130.
10. DeGrendele, H.C., P. Estess, and M.H. Siegelman. 1997. CD44 activation and associated primary adhesion is inducible via T cell receptor stimulation. J. Immunol. 159:2549-2553.
11. DeGrendele, H.D., P. Estess, and M.H. Siegelman. 1997. Requirement for CD44 in activated T cell extravasation into an inflamed site. Science. 278:672-675.
12. Mohamadzadeh, M., H.C. DeGrendele, P. Estess, and M.H. Siegelman. 1998. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA dependent primary adhesion. J. Clin. Invest. 101:97-108.
13. Cannistra, S.A., G.S. Kansas, J. Niloff, B. DeFranzo, Y. Kim, and C. Ottensmeier. 1993. Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. Cancer Res. 53:3830-3838.
14. Kansas, G.S., G.S. Wood, and M.O. Dailey. 1989. A family of cell-surface glycoproteins defined by a putative anti-endothelial cell receptor antibody in man. J. Immunol. 142:3050-3057.
15. Jalkanen, S., R.F. Bargatze, J. de los Toyos, and E.G. Butcher. 1987. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J. Cell Biol. 105:983-990.
16. de Belder, A.N., and K.O. Wik. 1975. Preparation and properties of fluorescein-labeled hyaluronate. Carbohydr. Res. 44:251-257.
17. Tan, E.M., A.S. Cohen, J.F. Fries, A.T. Masi, D.J. McShane, N.F. Rothfield, J.G. Schaller, N. Talal, and R.J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271-1277.
18. Cassidy, J.T., J.E. Levinson, J.C. Bass, J. Baum, E.J. Brewer, C.W. Fink, V. Hanson, J.C. Jacobs, A.T. Masi, J.G. Schaller, et al. 1986. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum. 29:274-281.
19. Dougados, M., S. van der Linden, R. Juhlin, B. Huitfeldt, B. Amor, A. Calin, A. Cats, B. Dijkmans, I. Olivieri, G. Pasero, et al. 1991. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 34:1218-1227.
20. Fink, C.W. 1995. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J. Rheumatol. 22:1566-1569.
21. Ravelli, A., S. Viola, N. Ruperto, B. Corsi, G. Ballardini, and A. Martini. 1997. Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann. Rheum. Dis. 56:197-200.
22. Bombardier, C., D.D. Gladman, M.B. Urowitz, D. Caron, and C.H. Chang. 1992. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630-640.
23. Gladman, D.D. 1994. Indicators of disease activity, prognosis, and treatment of systemic lupus erythematosus. Curr. Opin. Rheumatol. 6:487-492.
24. Jones, D.A., O. Abbassi, L.V. McIntire, R.P. McEver, and C.W. Smith. 1993. P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys. J. 65:1560-1569.
25. Lawrence, M.B., and T.A. Springer. 1991. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell 65:859-873.
26. Abbassi, O., C.L. Lane, S. Krater, T.K. Kishimoto, D.C. Anderson, L.V. McIntire, and C.W. Smith. 1991. Canine neutrophil margination mediated by lectin adhesion molecule-1 in vitro. J. Immunol. 147:2107-2115.
27. Clark, R.A., R. Alon, and T.A. Springer. 1996. CD44 and hyaluronan-dependent rolling interactions of lymphocytes on tonsillar stroma. J. Cell Biol. 134:1075-1087.
28. Murakami, S., K. Miyake, C.H. June, P.W. Kincade, and R.J. Hodes. 1990. IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 145:3618-3627.
29. Yokoyama, W.M., F. Koning, P.J. Kehn, G.M. Pereira, G. Stingl, J.E. Coligan, and F.M. Shevach. 1988. Characterization of a cell surface-expressed disulfide-linked dimer involved in murine T cell activation. J. Immunol. 141:369-376.
30. Alcocer-Varela, J., M. Alarcon-Riquelme, A. Laffon, F. Sanchez-Madrid, and D. Alarcon-Segovia. 1991. Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2. J. Autoimmun. 4:935-945.
31. Cush, J.J., and P.E. Lipsky. 1988. Phenotypic analysis of synovial tissue and peripheral Wood lymphocytes isolated from patients with rheumatoid arthritis. Arthritis Rheum 31:1230-1238.
32. + T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. Scand. J. Immunol. 31:139-145.
33. Yu, D.T., R.J. Winchester, S.M. Fu, A. Gibofsky, H.S. Ko, and H.G. Kunkel. 1980. Peripheral Wood Ia-positive T cells. Increases in certain diseases and after immunization. J. Exp. Med. 151:91-100.
34. Butcher, E.C., and L.J. Picker. 1996. Lymphocyte homing and homeostasis. Science. 272:60-66.
35. Springer, T.A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 76:301-314.
36. Kansas, O.S. 1996. Selectins and their ligands - current concepts and controversies. Blood. 88:3259-3287.
37. Carlos, T.M., and J.M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood. 84:2068-2101.
38. Shimizu, Y., W. Newman, Y. Tanaka, and S. Shaw. 1992. Lymphocyte interactions with endothelial cells. Immunol. Today. 13:106-112.
39. Berlin, C., R.F. Bargatze, J.J. Campbell, A.U. vonAndrian, M.C. Szabo, S.R. Hasslen, R.D. Nelson, E.L. Berg, S.L. Erlandsen, and E.C. Butcher. 1995. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell. 80:413-422.
40. Jones, D.A., L.V. McIntire, C.W. Smith, and L.J. Picker. 1994. A two-step adhesion cascade for T cell endothelial cell interactions under flow conditions. J. Clin. Invest. 94:2443-2450.
41. Silverman, E.D., B. Isacovics, D. Petsche, and R.M. Laxer. 1993. Synovial fluid cells in juvenile arthritis: evidence of selective T cell migration to inflamed tissue. Clin. Exp. Immunol. 91:90-95.
42. Haynes, B.F., L.P. Hale, S.M. Denning, P.T. Le, and K.H. Singer. 1989. The role of leukocyte adhesion molecules in cellular interactions: implications for the pathogenesis of inflammatory synovitis. Springer Semin. Immunopathol. 11:163-185.
43. Panayi, G.S., J.S. Lanchbury, and G.H. Kingsley. 1992. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis [editorial]. Arthritis Rheum. 35:729-735.
44. Cush, J.J., and P.E. Lipsky. 1991. Cellular basis for rheumatoid inflammation. Clin. Orthop. 265:9-22.
45. Hemler, M.E., D. Glass, J.S. Coblyn, and J.G. Jacobson. 1986. Very late activation antigens on rheumatoid synovial fluid T lymphocytes. Association with stages of T cell activation. J. Clin. Invest. 78:696-702.
46. Spronk, P.E., B.T.F.v.d. Gun, P.C. Limburg, and C.G. Kallenberg. 1993. B cell activation in clinically quiescent systemic lupus erythematosus (SLE) is related to immunoglobulin levels, but not to levels of anti-dsDNA, nor to concurrent T cell activation. Clin. Exp. Immunol. 93:39-44.
47. Mato, T., K. Masuko, Y. Misaki, N. Hirose, K. Ito, Y. Takemoto, K. Izawa, S. Yamamori, T. Kato, K. Nishioka, et al. 1997. Correlation of clonal T cell expansion with disease activity in systemic lupus erythematosus. Int. Immunol. 9:547-554.
48. Kotzin, B.L. 1996. Systemic lupus erythematosus. Cell. 85:303-306.
49. Murakami, M., S. Kumagai, M. Sugita, K. Iwai, and H. Imura. 1992. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone. Clin. Exp. Immunol. 90:245-250.
50. Wofsy, D., and W.E. Seaman. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378-391.
51. Ando, D.G., E.E. Sercarz, and B.H. Hahn. 1987. Mechanisms of T and B cell collaboration in the in vitro production of anti-DNA antibodies in the NZB/NZW F1 murine SLE model. J. Immunol. 138:3185-3190.
52. Rajagopalan, S., T. Zordan, G.C. Tsokos, and S.K. Datta. 1990. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8-T helper cell lines that express the gamma delta T-cell antigen receptor. Proc. Natl. Acad. Sci. USA. 87:7020-7024.
53. + T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol. 143:103-112.
54. Wofsy, D., and W.E. Seaman. 1987. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. J. Immunol. 138:3247-3253.
55. Dayal, A.K., and G.M. Kammer. 1996. The T cell enigma in lupus. Arthritis Rheum. 39:23-33.
56. Mohan, C., Y. Shi, J.D. Laman, and S.K. Datta. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J. Immunol. 154:1470-1480.
57. Finck, B.K., P.S. Linsley, and D. Wofsy. 1994. Treatment of murine lupus with CTLA4Ig. Science. 265:1225-1227.
58. Morimoto, C., D.A. Hafler, H.L. Weiner, N.L. Letvin, M. Hagan, J. Daley, and S.F. Schlossman. 1987. Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody. N. Engl. J. Med. 316:67-72.
59. Morimoto, C., A.D. Steinberg, N.L. Letvin, M. Hagan, T. Takeuchi, J. Daley, H. Levine, and S.F. Schlossman. 1987. A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody. J. Clin. Invest. 79:762-768.
60. Youinou, P., Y.L. Pennec, M.A. Blaschek, A. Gentric, J. Jouquan, A. Lamour, and P. Angelidis. 1988. Activation of peripheral blood lymphocytes in patients with primary Sjogren's syndrome. Rheumatol. Int. 8:125-130.
61. Kitani, A., M. Hara, T. Hirose, K. Norioka, W. Hirose, M. Kawagoe, and H. Nakamura. 1986. Kinetic analysis of Ia expression on T cells in patients with systemic lupus erythematosus. J. Clin. Lab. Immunol. 19:59-63.
62. Potocnik, A.J., R. Kinne, H. Menninger, J. Zacher, F. Emmrich, and R.A. Kroczek. 1990. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand. J. Immunol. 31:213-224.
63. Kitas, G.D., M. Salmon, I.M. Allan, and P.A. Bacon. 1988. The T cell system in rheumatoid arthritis: activated or defective? Scand. J. Rheumatol. Suppl. 76:161-173.
64. Tsokos, G.C., G. Inghirami, S.R. Pillemer, A. Mavridis, and D.B. Magilavy. 1988. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin. Immunol. Immunopathol. 47:62-74.
65. Jasin, H.E., E. Lightfoot, L.S. Davis, R. Rothlein, R.B. Faanes, and P.E. Lipsky. 1992. Amelioration of antigen-induced arthritis in rabbits treated with monoclonal antibodies to leukocyte adhesion molecules. Arthritis Rheum. 35:541-549.
66. Iigo, Y., T. Takashi, T. Tamatani, M. Miyasaka, T. Higashida, H. Yagita, K. Okumura, and W. Tsukada. 1991. ICAM-1-dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats. J. Immunol. 147:4167-4171.
67. Kavanaugh, A.F., L.S. Davis, L.A. Nichols, S.H. Norris, R. Rothlein, L.A. Scharschmidt, and P.E. Lipsky. 1994. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum. 37:992-999.